Release of peptide leukotrienes into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatics.
Picado
C
C
Servei de Pneumologia, Hospital Clinic, Facultat de Medicina, Barcelona, Spain.
Ramis
I
I
Rosellò
J
J
Bulbena
O
O
Plaza
V
V
Gelpi
E
E
D001241:Aspirin / Q000009:adverse effects*; D001249:Asthma / Q000139:chemically induced* / Q000378:metabolism; D004311:Double-Blind Method; D004342:Drug Hypersensitivity / Q000378:metabolism*; D006801:Humans; D007322:Instillation, Drug; D015289:Leukotrienes / Q000378:metabolism*; D009297:Nasal Mucosa / Q000378:metabolism*; D010455:Peptides / Q000378:metabolism*
D015289:Leukotrienes; D010455:Peptides; D001241:Aspirin